EC Number |
Application |
Reference |
---|
3.1.1.81 | agriculture |
potential of Lysinibacillus sp. Gs50 as a preventive and curative biocontrol agent. Lysinibacillus sp. Gs50 can degrade acyl homoserine lactones produced by Pectobacterium carotovorum subsp. carotovorum, a common cause of soft rot. This quorum quenching activity causes a decrease in production of plant cell wall degrading enzymes of Pectobacterium carotovorum subsp. carotovorum and attenuates symptoms of soft rot in experimental infection of potato, carrot and cucumber |
-, 751959 |
3.1.1.81 | agriculture |
zwittermicin A, a hybrid polyketidepeptide antibiotic, and N-acyl -homoserine-lactonase, as quorum-quenching enzyme, have the potential to prevent the virulence of Erwinia carotovora, which is a major pathogen of soft rot |
691409 |
3.1.1.81 | analysis |
the enzyme can serve as biosensor for detection of quorum-sensing inhibitors or activators, overview |
-, 692375 |
3.1.1.81 | biotechnology |
bacteria harboring the qsdA gene interfere very efficiently with quorum-sensing-regulated functions, demonstrating that qsdA is a valuable tool for developing quorum-quenching procedures |
690525 |
3.1.1.81 | biotechnology |
extreme temperature and pH resistance, resistance to proteases, wide substratum spectrum, and high specific activity enable the application of this QQ enzyme in a wide range of biotechnological applications |
749729 |
3.1.1.81 | drug development |
Ahl-1 lactonase is considered a promising therapeutic agent to inhibit Pseudomonas aeruginosa pathogenicity with no fear of emergence of resistance |
749695 |
3.1.1.81 | drug development |
MomL significantly attenuates the virulence of Pseudomonas aeruginosa in a Caenorhabditis elegans infection model, which suggests that MomL has the potential to be used as a therapeutic agent |
-, 749656 |
3.1.1.81 | drug development |
potential use of Aii20J in the control of the expression of virulence and adaptation genes in important human pathogens |
749729 |
3.1.1.81 | drug development |
the AHL-lactonase from Enterobacter aerogenes VT66 can be used as antibiofilm therapeutics in Pseudomonas aeruginosa associated biomedical applications |
-, 750821 |
3.1.1.81 | drug development |
the enzyme significantly inhibits the biofilm formation and attenuates extracellular proteolytic activity and pyocyanin production of Pseudomonas aeruginosa PAO1, which indicates the potential application of AiiK as a biocontrol agent or an anti-pathogenic drug |
-, 752246 |